Prevalence of factors associated with the duration of exclusive breastfeeding during the first 6 months of life in the INMA birth cohort in Gipuzkoa.
Oribe M, Lertxundi A, Basterrechea M, Begiristain H, Santa Marina L, Villar M, Dorronsoro M, Amiano P, Ibarluzea J.
Gac. Sanit. 2015; 29: 4-9. FI: 1.186 (Q3).
Compliance of nutritional recommendations of Spanish pregnant women according to sociodemographic and lifestyle characteristics: a cohort study.
Villar M, Amiano P, Rodriguez C, Santa Marina L, Mozo I Vioque J, Navarrete-Munoz EM, Romaguera D, Valvi D, Fernandez A, Tardon A, Ibarluzea J.
Nutr. Hosp. 2015; 31: 1803-1812. FI: 1.040 (Q4).
Effectiveness of non-pharmaceutical measures in preventing pediatric influenza: a case-control study.
Torner N, Soldevila N, Garcia JJ, Launes C, Godoy P, Castilla J, Domínguez A, CIBERESP Cases and Controls in Pandemic Influenza Working Group, Spain.
BMC Public Health. 2015; 15: 543-0. FI: 2.264 (Q2).
Etiology, clinical presentation and outcome of severe viral acute childhood encephalitis (ECOVE study).
Flores-Gonzalez JC, Jordan-Garcia I, Turon-Vinas E, Montero-Valladares C, Tellez-Gonzalez C, Fernandez-Carrion F, Garcia-Iniguez JP, Onate-Vergara E, Rodriguez-Nunez A.
Rev. Neurologia. 2015; 61: 7-13. FI: 0.830 (Q4).
Detection of bacteria and viruses in the pleural effusion of children and adults with community-acquired pneumonia.
Marimon JM, Morales M, Cilla G, Vicente D, Perez-Trallero E.
Future Microbiol. 2015; 10: 909-915. FI: 4.275 (Q1).
Helicobacter pylori Infection in Children. Antimicrobial Resistance and Treatment Response.
Montes M, Villalon FN, Eizaguirre FJ, Delgado M, Munoz-Seca IM, Fernandez-Reyes M, Perez-Trallero E.
Helicobacter. 2015; 20: 169-175. FI: 4.106 (Q1).
Biodegradation of bisphenol A by the newly-isolated Enterobacter gergoviae strain BYK-7 enhanced using genetic manipulation.
Badiefar L, Yakhchali B, Rodriguez-Couto S, Veloso A, Garcia-Arenzana J, Matsumura Y, Khodabandeh M.
RSC Adv. 2015; 5: 29563-29572. FI: 3.840 (Q1).
CIBERESP Cases Controls Pandemic I. 2009 H1N1: risk factors for hospitalization in a matched case-control study.
Launes C, García-García JJ, Martínez-Planas A, Moraga F, Astigarraga I, Aristegui J, Korta J, Salado C, Quintana JM, Soldevila N, Domínguez A.
Eur. J. Pediatr. 2012; 171: 1127-1131. FI: 1.879 (Q2).
Circulation of other respiratory viruses and viral co-infection during the 2009 pandemic influenza.
Navarro-Marí JM, Pérez-Ruiz M, Galán Montemayor JC, Marcos Maeso MÁ, Reina J, de Oña Navarro M, Cilla Eguiluz CG.
Enferm. Infec. Microbiol. Clin. 2012; 30 (4): 25-31. FI: 1.491 (Q3).
Decline and Rise of the Antimicrobial Susceptibility of Streptococcus pneumoniae Isolated from Middle Ear Fluid in Children: Influence of Changes in Circulating Serotypes.
Pérez-Trallero E, Marimón JM, Alonso M, Ercibengoa M, García-Arenzana JM.
Antimicrob. Agents Chemother. 2012; 56: 3989-3991. FI: 4.841 (Q1).
HTLV Spanish Study Grp. Development of Tropical Spastic Paraparesis in Human T-Lymphotropic Virus Type 1 Carriers Is Influenced by Interleukin 28B Gene Polymorphisms.
Treviño A, Lopez M, Vispo E, Aguilera A, Ramos JM, Benito R, Roc L, Eiros JM, De Mendoza C, Soriano V.
Clin. Infect. Dis. 2012; 55: 1-4. FI: 9.154 (Q1).
CIBERESP Cases Controls Pandemic. Effectiveness of hand hygiene and provision of information in preventing influenza cases requiring hospitalization.
Godoy P, Castilla J, Delgado-Rodríguez M, Martin V, Soldevila N, Alonso J, Astray J, Baricot M, Cantón R, Castro A, Gonzalez-Candelas F, Mayoral JM, Quintana JM, Pumarola T, Tamames S, Domínguez A.
Prev. Med. 2012; 54: 434-439. FI: 3.216 (Q1).
CIBERESP Cases Controls Pandemic. Effectiveness of pandemic and seasonal influenza vaccines in preventing pandemic influenza-associated hospitalization.
Domínguez A, Castilla J, Godoy P, Delgado-Rodríguez M, Martin V, Sáez M, Soldevila N, Quintana JM, Mayoral JM, Astray J, González-Candelas F, Cantón R, Tamames S, Castro A, Baricot M, Alonso J, Pumarola T.
Vaccine. 2012; 30: 5644-5650. FI: 3.766 (Q1).
Fatal Neisseria meningitidis serogroup X sepsis in immunocompromised patients in Spain. Virulence of clinical isolates.
Vicente D, Esnal O, Pérez-Trallero E.
J. Infect. 2012; 64: 184-187. FI: 4.126(Q1).